Tables S1, S2 and S3 from Risk of Prostate Cancer–related Death Following a Low PSA Level in the PLCO Trial
Year: 2023
Type: other
Abstract: Table S1: Demographics and baseline PSA Levels by Age; Table S2: Demographics and baseline PSA Levels by Race/Ethnicity; Table S3: Cumulative incidence of prostate cancer and aggressive disease at 2, 5, and 10 years, and prostate cancer mortality, for men with baseline PSA {less than or equal to}1 ng/ml, by age
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W4362635387
